Document is current
Any future updates will be listed below
-
Authors
Schoefs, Elise https://orcid.org/0000-0003-3542-6936
Desmet, Thomas https://orcid.org/0000-0001-7630-4850
Lerinckx, Evelyn
Waele, Liesbeth De https://orcid.org/0000-0001-7126-575X
Geuens, Sam https://orcid.org/0000-0003-4527-9319
Pelicaen, Conny
Meeus, Luc
Simoens, Steven https://orcid.org/0000-0002-9512-2005
Audenhove, Chantal Van https://orcid.org/0000-0002-5504-5439
Mommen, Mieke
Janssens, Rosanne https://orcid.org/0000-0003-1982-4176
Huys, Isabelle https://orcid.org/0000-0002-4738-8298
-
Funding
Funding for this research was provided by:
PROMISE Fund (PROMISE Fund (BE))
Fonds Wetenschappelijk Onderzoek (1SE9423N)
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 13 January 2025
First Online: 10 March 2025
Declarations
:
: This study was reviewed and approved by the Ethical Committee Research UZ/KU Leuven [Belgium; reference S66893]. All participants provided their informed consent to participate in this study prior to the conduct of the interviews.
: Not applicable.
: Mieke Mommen works for Pfizer NV, Belgium. At the time of conducting this research Rosanne Janssens was affiliated with KU Leuven, however, at the time of drafting this manuscript, she was employed by Evidera, London, UK.
